Jonathan Gelfond
The University of Texas at San Antonio Health Science Center
Papers
1
Total Citations
20
H-Index
1
About
Jonathan Gelfond is a urologic oncologist and researcher whose work centers on the surgical management of kidney cancer, with a particular focus on comparing minimally invasive and open surgical techniques. His most cited study, a 2022 analysis of survival outcomes after radical nephrectomy for stage I and II renal cell carcinoma, has garnered 20 citations and provides critical evidence that minimally invasive approaches yield comparable oncologic results to open surgery while offering patients faster recovery. This contribution directly informs clinical decision-making, helping surgeons and patients weigh the trade-offs between surgical approaches. Gelfond’s research is notable for its emphasis on real-world outcomes, bridging the gap between clinical trials and everyday practice. By demonstrating that minimally invasive nephrectomy does not compromise survival in early-stage disease, his work supports the broader adoption of less invasive techniques, ultimately improving patient quality of life. His findings are frequently referenced in guidelines and surgical discussions, underscoring their impact on the field.
Research Focus
Key Achievements
Top Papers
- 1